Table 1.
Baseline patient characteristics for model training and retrospective evaluation.
| Characteristics | Categories | Model training cohort N = 5139 patients |
Retrospective cohort N = 2385 patients |
|---|---|---|---|
| Age, years | Median (range) | 64 (18–100) | 65 (18–101) |
| Gender | Male | 47% | 47% |
| Female | 53% | 53% | |
| Ethnicity | Hispanic | 7% | 7% |
| Non-Hispanic | 93% | 93% | |
| Race | White | 88% | 87% |
| Black | 1% | 1% | |
| Asian | 2% | 2% | |
| Other | 8% | 8% | |
| Unknown | 1% | 2% | |
| Cancer Sitesa | Breast | 24% | 23% |
| Unspecified primary malignant neoplasms | 22% | 21% | |
| Non-melanoma skin neoplasms | 20% | 22% | |
| Prostate | 15% | 16% | |
| Lung | 8% | 10% | |
| Multiple myeloma | 7% | 8% | |
| Non-Hodgkin’s lymphoma | 11% | 11% | |
| Leukemia | 8% | 9% | |
| Colon | 6% | 6% | |
| Melanoma of skin | 9% | 8% | |
| Bone/connective tissue | 8% | 9% | |
| Brain | <5% | 5% | |
| Head and neck | 6% | 6% |
aOnly cancer sites with ≥5% prevalence at baseline are listed in the table.